Holen Sie sich die Stockscreener-App
1.15
4.17%
-0.05
Handel nachbörslich:
1.15
Schlusskurs vom Vortag:
$1.20
Offen:
$1.2
24-Stunden-Volumen:
13,980
Relative Volume:
0.06
Marktkapitalisierung:
$3.70M
Einnahmen:
$2.52M
Nettoeinkommen (Verlust:
$-24.36M
KGV:
-0.0278
EPS:
-41.3755
Netto-Cashflow:
$-2,900
1W Leistung:
+6.48%
1M Leistung:
+9.52%
6M Leistung:
-92.73%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.15
$1.24
1-Wochen-Bereich:
$1.04
$1.24
52-Wochen-Spanne:
$0.9301
$19.75
Park Ha Biological Technology Co Ltd Stock (BYAH) Company Profile
Compare BYAH vs PG, UL, CL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BYAH
Park Ha Biological Technology Co Ltd
|
1.15 | 3.86M | 2.52M | -24.36M | -2,900 | -41.38 |
PG
Procter Gamble Co
|
144.90 | 333.97B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.42 | 128.22B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
86.33 | 68.31B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
17.37 | 32.93B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
97.20 | 31.75B | 16.56B | 1.75B | 1.84B | 6.36 |
Park Ha Biological Technology Co Ltd Aktie (BYAH) Neueste Nachrichten
Park Ha Biological Technology Co., Ltd. (PHH) Competitors - Meyka
Park Ha Biological Technology : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) - marketscreener.com
19,050,000 Class B Ordinary Shares of Park Ha Biological Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-APR-2026. - marketscreener.com
[20-F/A] Park Ha Biological Technology Co., Ltd. Amends Annual Report (Foreign Issuer) - Stock Titan
Park Ha Bio (BYAH) Stock: Key Drivers Analysis (-2.29%) 2026-04-20Volume Spike - Xã Thanh Hà
Yanan Shan Net Worth (2026) - GuruFocus
Park Ha Bio (BYAH) Stock: Warning Signs (Technical Weakness) 2026-04-18Beta Signals - Xã Châu Thành
Qixiong Sheng Net Worth (2026) - GuruFocus
Xiaozhong Yu Net Worth (2026) - GuruFocus
Xiaoyan Zhu Net Worth (2026) - GuruFocus
Xiaoqiu Zhang Net Worth (2026) - GuruFocus
Xinyu Li Net Worth (2026) - GuruFocus
Park Ha Biological (BYAH) files $300M shelf to sell shares, warrants, debt - Stock Titan
Rosen Law Firm Encourages Park Ha Biological Technology Co. Ltd. Investors to Inquire About Securities Class Action Investigation – BYAH - Business Wire
Stock List: Research Stocks from Around the World - GuruFocus
Park Ha Biological Tech (BYAH) Stock Analysis Report | Financials & Insights - Benzinga
Market Recap: Can NCR Voyix Corporation disrupt its industryQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
Volatility Watch: Is Dynagas LNG Partners LP Preferred Security a speculative investment2026 Update & Stepwise Trade Signal Implementation - baoquankhu1.vn
Is Park Ha Bio (BYAH) Stock a Buy Now | Price at $1.03, Down 3.55%Growth Investing - Newser
Gains Report: Can YEXT withstand a market correction2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Is Park Ha Bio (BYAH) Stock exposed to global risks | Price at $1.05, Up 2.94%Retail Picks - Newser
AXIL PE Ratio & Valuation, Is AXIL Overvalued - Intellectia AI
Targets Report: What is the earnings history of Park Ha Biological Technology Co Ltd2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
Park Ha Biological (BYAH) CFO discloses 2,500 Class A shares - Stock Titan
Will Park Ha Bio (BYAH) Stock Miss Expectations | Price at $1.02, Down 2.86%Most Watched Stocks - Newser
BYAH PE Ratio & Valuation, Is BYAH Overvalued - Intellectia AI
BYAH Stock Analysis: Park Ha Biological Technology posts 0.96% gain at 1.05 in biotech - Newser
BYAH : Park Ha Biological Technology Co., Ltd. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
Short Covering: Does Park Ha Biological Technology Co Ltd have declining or rising EPS2026 Technical Overview & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Aug Outlook: Is Park Ha Biological Technology Co Ltd stock heavily shorted2026 Analyst Calls & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Stock Recap: What is the earnings history of Park Ha Biological Technology Co Ltd2026 Catalysts & Comprehensive Market Scan Insights - baoquankhu1.vn
S P Trends: What are Park Ha Biological Technology Co Ltds earnings expectationsQuarterly Profit Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Chart Watch: Will Park Ha Biological Technology Co Ltd outperform its industry peersEarnings Growth Report & AI Forecasted Stock Moves - baoquankhu1.vn
BYAH Should I Buy - Intellectia AI
Momentum Shift: Is Park Ha Biological Technology Co Ltd exposed to political riskTrade Volume Summary & Low Drawdown Investment Strategies - baoquankhu1.vn
Short Covering: Can Park Ha Biological Technology Co Ltd be the next market leader2026 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
BYAH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Park Ha Biological Technology Announces Director Li Wang’s Resignation - tipranks.com
Director Li Wang resigns from Park Ha Biological (BYAH) board - Stock Titan
11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session - Benzinga
Returns Recap: What is the earnings history of Park Ha Biological Technology Co LtdWeekly Stock Recap & Pattern Based Trade Signal System - baoquankhu1.vn
Movement Recap: What is the implied volatility of Park Ha Biological Technology Co. Ltd2026 Setups & Daily Momentum Trading Reports - baoquankhu1.vn
Will XXGCC stock outperform growth indexesMarket Sentiment Report & Growth Focused Stock Pick Reports - Naître et grandir
Park Ha Biological Technology regains Nasdaq minimum bid price compliance - Investing.com Australia
Gains Report: Is Park Ha Biological Technology Co Ltd still a buy after recent gainsWeekly Market Summary & Pattern Based Trade Signal System - baoquankhu1.vn
Park Ha Biological Technology regains Nasdaq minimum bid price compliance By Investing.com - Investing.com South Africa
Park Ha Biological Technology Regains Nasdaq Minimum Bid Price Compliance - TipRanks
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session - Benzinga
Sentiment Watch: What is the earnings history of Park Ha Biological Technology Co LtdJuly 2025 Market Mood & Consistent Growth Equity Picks - baoquankhu1.vn
China rules and HFCAA risks shape Park Ha Biological (NASDAQ: BYAH) outlook - Stock Titan
Finanzdaten der Park Ha Biological Technology Co Ltd-Aktie (BYAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.20%
3.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):